New smart polymer that responds to low-power NIR light could treat cancers

NewsGuard 100/100 Score

Scientists are reporting development and successful initial testing of the first practical "smart" material that may supply the missing link in efforts to use in medicine a form of light that can penetrate four inches into the human body. Their report on the new polymer or plastic-like material, which has potential for use in diagnosing diseases and engineer new human tissues in the lab, appears in ACS' journal Macromolecules.

Adah Almutairi and colleagues explain that near-infrared (NIR) light (which is just beyond what humans can see) penetrates through the skin and almost four inches into the body, with great potential for diagnosing and treating diseases. Low-power NIR does not damage body tissues as it passes. Missing, however, are materials that respond effectively to low-power NIR. Plastics that disintegrate when hit with NIR, for instance, could be filled with anti-cancer medicine, injected into tumors, and release the medicine when hit with NIR. Current NIR-responsive smart materials require high-power NIR light, which could damage cells and tissues. That's why Almutairi's team began research on development of a new smart polymer that responds to low-power NIR light.

Hit with low-power NIR, their new material breaks apart into small pieces that seem to be nontoxic to surrounding tissue. The researchers envision, for instance, putting the polymer in an implantable "hydrogel," which is a water-containing flexible material used for tissue engineering and drug delivery. A hydrogel with the new polymer could release medications or imaging agents when hit with NIR. "To the best of our knowledge, this is the first example of a polymeric material capable of disassembly into small molecules in response to harmless levels of irradiation," say the researchers.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine